Delivery Order SPE2DR25D3301-SPE2DR26F19VD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count) with a ceiling value of $10,223.24. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by November 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Lenvima 10 mg daily dose (30-count) with a ceiling value of $10,773.72. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to the pharmaceutical distributor. The order is scheduled for completion by December 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 20, 2025, for the supply of Lenvima 10 mg daily dose tablets (30-count units) with a ceiling value of $10,773.72. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Lenvima 14 mg daily dose tablets (60-count package) valued at $29,732.85. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 24, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count package. This firm fixed-price delivery order, valued at $10,223.24, is scheduled for completion by August 12, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania location. The award was not designated as a set-aside contract and was competitively awarded, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count quantity, with a ceiling value of $10,223.24 and a firm fixed price structure. The contract carries an ultimate completion date of November 18, 2025, and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Lenvima 8 mg daily dose tablets in a quantity of 60 units, valued at $10,773.72. This contract represents a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and was competitively awarded without set-aside provisions. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lenvima 14 mg daily dose tablets (60-count units) with a contract ceiling value of $10,223.24. This firm fixed price delivery order, which is expected to be completed by September 9, 2025, represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $10,773.72 to supply Lenvima 10 mg daily dose tablets (30-count) for delivery by January 13, 2026. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, representing a child contract under AmerisourceBergen's larger federal pharmaceutical supply agreement. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for the supply of LENVIMA 18 mg daily dose in a 90-day supply. The contract, executed on April 24, 2025, with completion targeted for May 15, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19VDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Lenvima (levatinib) 10 mg daily dose tablets in quantities of 30-day supplies. This is a firm fixed-price delivery order with a ceiling value of $10,773.72 and an ultimate completion date of January 14, 2026. The contract was competitively awarded without a set-aside designation, and performance will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical supplier to the Defense Health Agency and military healthcare systems, supplying a broad portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's extensive federal contract awards demonstrate its capability to meet federal procurement requirements through open competition. The DLA Medical Supply Chain maintains relationships with multiple contractors to ensure reliable pharmaceutical support for military and veteran healthcare operations worldwide, with the agency planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts that may involve multiple regional awards among qualified vendors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 12/21/25 |